The FDA issued a Class I recall — the most serious recall classification — for some of Medtronic’s cardiac resynchronization therapy and implantable cardioverter defibrillators. Here are four things ...

WASHINGTON (Reuters) - Patient injury reports for the tiny wires used with Medtronic's implantable heart devices jumped dramatically in the past year, a consumer group said on Tuesday, a day after the ...

Medtronic (NYSE: MDT) today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.

CHICAGO (Reuters) - Medtronic Inc said on Tuesday a study of device therapy in patients with mild heart failure missed its primary goal on a measure of disease progression, but some patients saw their ...

More and more medical studies show that heart issues in women are not only underdiagnosed but should be treated differently. A study Medtronic designed to test its Evolut TAVR (transcatheter aortic ...

For a person with a pacemaker or implantable defibrillator, a weekend or evening trip to the emergency room or urgent care can become an hours-long slog of waiting for the "expert" to show up.

Medtronic is cautioning physicians to be careful when using a popular new heart valve after 19 patients died from severe blood vessel trauma caused by the device, reports the Star Tribune. Minneapolis ...

Boston Scientific raised its annual profit forecast on Wednesday, after beating third-quarter profit estimates on strong ...

Medtronic (NYSE:MDT) strengthens its healthcare offerings. Key sectors of Medtronic show growth. S&P 500 futures reflects trends in healthcare. Medtronic plc (NYSE:MDT) is a global leader in medical ...